What is the appropriate protocol for initiating and managing an intravenous insulin infusion in an adult patient?

How to Give Insulin Infusion in Critically Ill Adults

Initiate continuous intravenous insulin infusion when blood glucose is persistently ≥180 mg/dL (≥10 mmol/L), using a standardized 1 unit/mL concentration after priming tubing with 20 mL waste volume, and target a glucose range of 140-200 mg/dL (7.8-11.1 mmol/L). 1

When to Start IV Insulin

• Begin insulin infusion therapy when two consecutive blood glucose readings are ≥180 mg/dL (≥10 mmol/L) 1
• This trigger threshold is intentionally lower than the treatment target to prevent prolonged hyperglycemia 1
• IV insulin is mandatory for patients with type 1 diabetes, hemodynamically unstable patients, and those on vasopressors 1

Preparation and Administration

Insulin Solution Preparation

• Prepare insulin as a continuous infusion at 1 unit/mL concentration using human regular insulin 1
• Prime new IV tubing with 20 mL waste volume before connecting to patient to ensure accurate dosing 1
• Use standardized concentrations across your institution to minimize errors 1

Target Glucose Range

• Target blood glucose of 140-200 mg/dL (7.8-11.1 mmol/L) for most critically ill adults 1
• Avoid intensive targets of 80-139 mg/dL as these increase hypoglycemia risk without mortality benefit 1
• The 2024 Society of Critical Care Medicine guidelines explicitly recommend against tight glycemic control 1

Monitoring Requirements

Glucose Monitoring Frequency

• Check blood glucose every 1 hour or more frequently during periods of glycemic instability 1
• Continue hourly monitoring until glucose stabilizes within target range 1
• Use point-of-care glucose meters, but be aware that accuracy may be reduced in patients with hypotension, edema, or on vasopressors 1

Clinical Decision Support

• Use an explicit protocol-driven approach rather than ad hoc physician orders 1, 2
• Nurse-led insulin protocols achieve target glucose faster (within 1-2 days in 62.5% vs 12.5% with standard care) and reduce ICU length of stay 2
• Protocols should include specific titration algorithms based on current glucose and rate of change 1

Critical Pitfalls to Avoid

When NOT to Use IV Insulin

• Do not initiate IV insulin in patients with:
  • Peripheral edema (impairs subcutaneous absorption, but doesn't affect IV) 1
  • Frequent interruptions of nutrition for procedures 1
  • Hypothermia 1
• In these situations, wait until clinical status stabilizes 1

Hypoglycemia Prevention

• Point-of-care meters may incorrectly diagnose hypoglycemia in 32% of hypotensive patients 1
• Confirm suspected hypoglycemia with laboratory measurement if patient is on vasopressors 1
• Hypoglycemia risk is similar between responders and non-responders when protocols are followed 3

Transitioning Off IV Insulin

Timing of Transition

• Transition to subcutaneous insulin only after:
  • Clinical stability is achieved 1
  • Patient is off vasopressors 1
  • Peripheral edema has resolved 1
  • No planned interruptions of nutrition 1

Transition Protocol

• Use a protocol-driven basal/bolus subcutaneous regimen 1
• Overlap subcutaneous and IV insulin appropriately - give first subcutaneous dose, then continue IV insulin for the appropriate duration based on insulin type used 1, 4
• Proper overlap occurred in only 62.5% of patients in one audit, highlighting this as a common error 4
• If subcutaneous regimen fails to maintain glucose <180 mg/dL, resume IV insulin infusion 1

Special Considerations

Non-ICU Settings

• IV insulin can be safely administered outside the ICU when targeting 140-180 mg/dL 5
• In non-ICU patients, 84% achieved glucose ≤180 mg/dL with median time of 5.7 hours 5
• Limit infusion duration in non-critical care settings 5

Subcutaneous Alternatives

• Subcutaneous insulin may be considered for selected stable ICU patients who don't meet criteria for mandatory IV insulin 1
• However, IV insulin remains preferred for optimal glycemic control in most critically ill patients 1, 6